Stem Cell Therapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LCTX | C | Lineage Cell Therapeutics, Inc. | 5.71 | |
LSTA | C | Lisata Therapeutics, Inc. | -4.29 | |
BRTX | F | BioRestorative Therapies, Inc. | -0.91 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | A | iShares Microcap ETF | 0.04 | |
IWM | B | iShares Russell 2000 ETF | 0.01 | |
IWO | B | iShares Russell 2000 Growth ETF | 0.01 | |
VXF | B | Vanguard Extended Market ETF | 0.0 | |
VTI | A | Vanguard Total Stock Market ETF | 0.0 |
Compare ETFs
- Stem Cell Therapy
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition.Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Research is underway to develop various sources for stem cells, as well as to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes and heart disease, among others.
Stem-cell therapy has become controversial following developments such as the ability of scientists to isolate and culture embryonic stem cells, to create stem cells using somatic cell nuclear transfer and their use of techniques to create induced pluripotent stem cells. This controversy is often related to abortion politics and to human cloning. Additionally, efforts to market treatments based on transplant of stored umbilical cord blood have been controversial.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles